Compare $NRXS vs $ZOMDF | Chartloom

Compare

$NRXS vs $ZOMDF

Neuraxis Inc · Zomedica Corp

NRXS

Neuraxis Inc

ZOMDF

Zomedica Corp

Compare $NRXS vs $ZOMDF

Comparing Neuraxis Inc and Zomedica Corp

NRXSNeuraxis Inc

ZOMDFZomedica Corp

NRXSNeuraxis Inc

Market cap

$86M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.62x

Rev growth (TTM)

65.2%

YTD performance

55.4%

52W performance

121.4%

FCF yield

-6.7%

ZOMDFZomedica Corp

Market cap

$81M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-1.4%

YTD performance

-24.7%

52W performance

21.5%

FCF yield

-11.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NRXS

ZOMDF

Detailed metrics comparison

NRXS

Neuraxis Inc

ZOMDF

Zomedica Corp

Market Cap

NRXS$86M

ZOMDF$81M

Enterprise Value

NRXS$78M

ZOMDF$74M

Price

NRXS$6.93

ZOMDF$0.08

P/E Ratio

NRXSN/A

ZOMDFN/A

P/S Ratio

NRXS16.14x

ZOMDF4.42x

EV/Sales

NRXS14.58x

ZOMDF4.02x

EV/EBITDA

NRXS0.00x

ZOMDF0.00x

P/B Ratio

NRXS13.26x

ZOMDF0.71x

P/FCF Ratio

NRXSN/A

ZOMDFN/A

EV/FCF

NRXS-13.52x

ZOMDF-8.06x

PEG Ratio

NRXSN/A

ZOMDFN/A

Forward P/E (NTM)

NRXSN/A

ZOMDFN/A

Forward P/S (NTM)

NRXS6.62x

ZOMDFN/A

Revenue (TTM)

NRXS$5M

ZOMDF$18M

Revenue Growth (YoY)

NRXS65.2%

ZOMDF-1.4%

Forward Rev Growth

NRXS124.9%

ZOMDF29.2%

Gross Margin (TTM)

NRXS85.6%

ZOMDF62.9%

Operating Margin (TTM)

NRXS0.0%

ZOMDF0.0%

EBITDA Margin (TTM)

NRXS-143.1%

ZOMDF-28.7%

Net Margin (TTM)

NRXS-159.0%

ZOMDF-45.3%

FCF Margin (TTM)

NRXS-107.8%

ZOMDF-49.9%

Net Income (TTM)

NRXS$-8M

ZOMDF$-8M

FCF (TTM)

NRXS$-6M

ZOMDF$-9M

EPS (TTM)

NRXS-$0.70

ZOMDF-$0.01

ROE (TTM)

NRXS-16907.0%

ZOMDF-1672.0%

ROA (TTM)

NRXS-9933.0%

ZOMDF-1523.0%

ROIC (TTM)

NRXS-16465.0%

ZOMDF-1672.0%

Cash

NRXS$8M

ZOMDF$7M

Debt

NRXS$43K

ZOMDF$0

Net Cash/Debt

NRXS$8M

ZOMDF$7M

Current Ratio (TTM)

NRXS3.04x

ZOMDF6.43x

Quick Ratio (TTM)

NRXS2.83x

ZOMDF5.57x

Debt/Equity (TTM)

NRXS0.01x

ZOMDF0.00x

Debt/Assets (TTM)

NRXS0.0%

ZOMDF0.0%

Interest Coverage (TTM)

NRXSN/A

ZOMDFN/A

Net Debt/EBITDA (TTM)

NRXS0.00x

ZOMDF0.00x

Beta

NRXS1.40

ZOMDF1.36

52W Performance

NRXS121.4%

ZOMDF21.5%

YTD Performance

NRXS55.4%

ZOMDF-24.7%

% from 52W High

NRXS-25.7%

ZOMDF-47.8%

% from 52W Low

NRXS213.6%

ZOMDF37.5%

Asset Turnover (TTM)

NRXS0.69x

ZOMDF0.30x

FCF Yield (TTM)

NRXS-6.7%

ZOMDF-11.3%

Earnings Yield (TTM)

NRXS-9.9%

ZOMDF-10.3%

Dividend Yield (TTM)

NRXSN/A

ZOMDFN/A

Rule of 40

NRXS-42.6

ZOMDF-51.3

EV/GP/RG

NRXS0.12

ZOMDF0.11

Ticker research

View NRXS research View ZOMDF research

Metric	NRXS Neuraxis Inc	ZOMDF Zomedica Corp
Market & Valuation
Market Cap	$86M	$81M
Enterprise Value	$78M	$74M
Price	$6.93	$0.08
P/E Ratio	N/A	N/A
P/S Ratio	16.14x	4.42x
EV/Sales	14.58x	4.02x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.26x	0.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.52x	-8.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.62x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$18M
Revenue Growth (YoY)	65.2%	-1.4%
Forward Rev Growth	124.9%	29.2%
Profitability
Gross Margin (TTM)	85.6%	62.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-143.1%	-28.7%
Net Margin (TTM)	-159.0%	-45.3%
FCF Margin (TTM)	-107.8%	-49.9%
Net Income (TTM)	$-8M	$-8M
FCF (TTM)	$-6M	$-9M
EPS (TTM)	-$0.70	-$0.01
ROE (TTM)	-16907.0%	-1672.0%
ROA (TTM)	-9933.0%	-1523.0%
ROIC (TTM)	-16465.0%	-1672.0%
Financial Health
Cash	$8M	$7M
Debt	$43K	$0
Net Cash/Debt	$8M	$7M
Current Ratio (TTM)	3.04x	6.43x
Quick Ratio (TTM)	2.83x	5.57x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	1.36
52W Performance	121.4%	21.5%
YTD Performance	55.4%	-24.7%
% from 52W High	-25.7%	-47.8%
% from 52W Low	213.6%	37.5%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.30x
FCF Yield (TTM)	-6.7%	-11.3%
Earnings Yield (TTM)	-9.9%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-42.6	-51.3
EV/GP/RG	0.12	0.11
Ticker research	View NRXS research	View ZOMDF research

Valuation

P/S Ratio

ZOMDF

4.42x

NRXS

16.14x

EV/FCF

NRXS

-13.52x

ZOMDF

-8.06x

Growth & revenue

Revenue Growth TTM

NRXS

65.2%

ZOMDF

-1.4%

Forward Revenue Growth

NRXS

124.9%

ZOMDF

29.2%

Profitability & performance

Gross Margin

NRXS

85.6%

ZOMDF

62.9%

ROE

ZOMDF

-1672.0%

NRXS

-16907.0%

FCF Yield %

NRXS

-6.7%

ZOMDF

-11.3%

52-Week Performance

NRXS

121.4%

ZOMDF

21.5%

Detailed metrics comparison

NRXS

Neuraxis Inc

ZOMDF

Zomedica Corp

Market Cap

NRXS$86M

ZOMDF$81M

Enterprise Value

NRXS$78M

ZOMDF$74M

Price

NRXS$6.93

ZOMDF$0.08

P/E Ratio

NRXSN/A

ZOMDFN/A

P/S Ratio

NRXS16.14x

ZOMDF4.42x

EV/Sales

NRXS14.58x

ZOMDF4.02x

EV/EBITDA

NRXS0.00x

ZOMDF0.00x

P/B Ratio

NRXS13.26x

ZOMDF0.71x

P/FCF Ratio

NRXSN/A

ZOMDFN/A

EV/FCF

NRXS-13.52x

ZOMDF-8.06x

PEG Ratio

NRXSN/A

ZOMDFN/A

Forward P/E (NTM)

NRXSN/A

ZOMDFN/A

Forward P/S (NTM)

NRXS6.62x

ZOMDFN/A

Revenue (TTM)

NRXS$5M

ZOMDF$18M

Revenue Growth (YoY)

NRXS65.2%

ZOMDF-1.4%

Forward Rev Growth

NRXS124.9%

ZOMDF29.2%

Gross Margin (TTM)

NRXS85.6%

ZOMDF62.9%

Operating Margin (TTM)

NRXS0.0%

ZOMDF0.0%

EBITDA Margin (TTM)

NRXS-143.1%

ZOMDF-28.7%

Net Margin (TTM)

NRXS-159.0%

ZOMDF-45.3%

FCF Margin (TTM)

NRXS-107.8%

ZOMDF-49.9%

Net Income (TTM)

NRXS$-8M

ZOMDF$-8M

FCF (TTM)

NRXS$-6M

ZOMDF$-9M

EPS (TTM)

NRXS-$0.70

ZOMDF-$0.01

ROE (TTM)

NRXS-16907.0%

ZOMDF-1672.0%

ROA (TTM)

NRXS-9933.0%

ZOMDF-1523.0%

ROIC (TTM)

NRXS-16465.0%

ZOMDF-1672.0%

Cash

NRXS$8M

ZOMDF$7M

Debt

NRXS$43K

ZOMDF$0

Net Cash/Debt

NRXS$8M

ZOMDF$7M

Current Ratio (TTM)

NRXS3.04x

ZOMDF6.43x

Quick Ratio (TTM)

NRXS2.83x

ZOMDF5.57x

Debt/Equity (TTM)

NRXS0.01x

ZOMDF0.00x

Debt/Assets (TTM)

NRXS0.0%

ZOMDF0.0%

Interest Coverage (TTM)

NRXSN/A

ZOMDFN/A

Net Debt/EBITDA (TTM)

NRXS0.00x

ZOMDF0.00x

Beta

NRXS1.40

ZOMDF1.36

52W Performance

NRXS121.4%

ZOMDF21.5%

YTD Performance

NRXS55.4%

ZOMDF-24.7%

% from 52W High

NRXS-25.7%

ZOMDF-47.8%

% from 52W Low

NRXS213.6%

ZOMDF37.5%

Asset Turnover (TTM)

NRXS0.69x

ZOMDF0.30x

FCF Yield (TTM)

NRXS-6.7%

ZOMDF-11.3%

Earnings Yield (TTM)

NRXS-9.9%

ZOMDF-10.3%

Dividend Yield (TTM)

NRXSN/A

ZOMDFN/A

Rule of 40

NRXS-42.6

ZOMDF-51.3

EV/GP/RG

NRXS0.12

ZOMDF0.11

Ticker research

View NRXS research View ZOMDF research

Metric	NRXS Neuraxis Inc	ZOMDF Zomedica Corp
Market & Valuation
Market Cap	$86M	$81M
Enterprise Value	$78M	$74M
Price	$6.93	$0.08
P/E Ratio	N/A	N/A
P/S Ratio	16.14x	4.42x
EV/Sales	14.58x	4.02x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.26x	0.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.52x	-8.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.62x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$18M
Revenue Growth (YoY)	65.2%	-1.4%
Forward Rev Growth	124.9%	29.2%
Profitability
Gross Margin (TTM)	85.6%	62.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-143.1%	-28.7%
Net Margin (TTM)	-159.0%	-45.3%
FCF Margin (TTM)	-107.8%	-49.9%
Net Income (TTM)	$-8M	$-8M
FCF (TTM)	$-6M	$-9M
EPS (TTM)	-$0.70	-$0.01
ROE (TTM)	-16907.0%	-1672.0%
ROA (TTM)	-9933.0%	-1523.0%
ROIC (TTM)	-16465.0%	-1672.0%
Financial Health
Cash	$8M	$7M
Debt	$43K	$0
Net Cash/Debt	$8M	$7M
Current Ratio (TTM)	3.04x	6.43x
Quick Ratio (TTM)	2.83x	5.57x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	1.36
52W Performance	121.4%	21.5%
YTD Performance	55.4%	-24.7%
% from 52W High	-25.7%	-47.8%
% from 52W Low	213.6%	37.5%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.30x
FCF Yield (TTM)	-6.7%	-11.3%
Earnings Yield (TTM)	-9.9%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-42.6	-51.3
EV/GP/RG	0.12	0.11
Ticker research	View NRXS research	View ZOMDF research